
Thymalin
Thymic signals for an ageing immune system, approved in Russia since 1982.
- Evidence
- BHuman trials what's this?
Grade B. Russian clinical data and approval; longevity claims contested; little Western replication. - Also known as
- Thymus peptide bioregulator
- Class
- Polypeptide complex extracted from calf thymus; Khavinson immune bioregulator
What it is
The thymus, behind the breastbone, is where T-cells are trained. It starts shrinking at puberty and by your 60s and 70s has largely turned to fat. That decline (immunosenescence) helps explain why older people get more infections and cancers. Vladimir Khavinson, the researcher behind Epitalon, developed Thymalin in the 1970s to resupply the signals an aged thymus stops making. It’s different from Thymosin α-1, which is one defined peptide.
How it works
What the research shows
In people: decades of Russian studies, mostly in elderly people, report that short courses improved T-cell counts, the CD4:CD8 ratio and immune competence, and reduced infections2. Long-term follow-ups claimed up to a two-fold mortality reduction with periodic thymus-plus-pineal courses. That’s the headline, and also the weakest part1. In severe COVID-19 in older patients, adding Thymalin sped clinical improvement, lymphocyte recovery and the normalisation of inflammation markers3. In animals: it preserved thymic structure, slowed spontaneous tumours and extended lifespan1,2.
Evidence at a glance
| Use | Grade | Best evidence | Main gap | Read |
|---|---|---|---|---|
| Immune restoration | BHuman trials | T-cells restored, fewer infections2 | Russian, older methods | Genuine signal |
| Severe COVID-19 | BHuman trials | Faster recovery and immune regulation3 | Small, single setting | Notable |
| Longevity, mortality | DCommunity use | Claimed mortality reduction1 | Contested methods | Caution |
| Mechanism | ELab & animal | Thymus preserved; T-cell activity up | Preclinical | Consistent |
Dosing: what has been reported
| Setting | Figure | Route | Grade |
|---|---|---|---|
| Approved (Russia) | 10–20 mg daily for 5–10 days, repeated periodically | Intramuscular | B |
| Community | 5–20 mg/day in 5–10-day courses, 2–3 times a year, often with Epitalon | IM or SC | D |
Preparing & storing
Reconstitute the lyophilised powder for injection, keep it cold and dark, and don’t shake it. Because it’s an animal-derived biological extract, the supplier’s purity and consistency matter more than for a synthetic peptide.
Reported side effects
- Injection-site soreness
- Allergic reaction: it’s a foreign, calf-derived protein
- Occasional transient flu-like feeling as immunity is stimulated
Track a CBC with lymphocytes (and CD4/CD8 if available) before and after a course, and keep note of how often you get infections.
Who should avoid it
- Organ transplant recipients on immunosuppression
- Active lymphoma, leukaemia or autoimmune disease without specialist guidance
- Bovine-product allergy; pregnancy and breastfeeding
Regulatory status checked Oct 2026
| Body | Status | Detail |
|---|---|---|
| FDA (US) | Not approved | Research use only. |
| EMA (EU) | Not approved | — |
| Russia | Approved | Since 1982 for immune disorders and immunodeficiency. |
| WADA | Not listed | Low doping relevance. |
Long history, imperfect proof
Thymalin has decades of clinical use behind its immune-restoration effects, and a recent COVID study adds weight. Treat the dramatic lifespan claims sceptically, and choose a supplier who can document the extract’s quality.
References
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3–4):233–240. PMID 14523363
- Khavinson VKh, et al. Thymalin for immunocorrection and molecular aspects of its biological activity. PMC8365293
- Khavinson V, Shapovalov K, Linkova N, et al. Thymalin regulates immune status in severe COVID-19 older patients. Adv Gerontol. 2021.